Saturday, September 10, 2022 6:12:32 PM
In other words, they agree to negotiate an agreement at a later date.
Everything about PBIO and their "Partners" is flim-flam. The CEO of Safer Medical of Montana is a convicted counterfeiter. Another CEO , John Kaweseki of North Star Holdings: “According to the order, the case revolves around Clover Top Holdings, Inc. and its founder John Kaweske. The order states that in 2015 Kaweske and two other partners incorporated Clover Top Holdings, Inc. in Delaware with a principal place of business in Colorado to engage in the cannabis business. They are being sued by investors in Clover Top; the court describes the victims as self-described “victims of fraud, theft, and mismanagement.”....”The order states that Kaweske simultaneously created a competing marijuana operation that received ownership of the assets that originally belonged to or were intended to belong to Clover Top Holdings. According to the order, Kaweske and one of Clover Top Holdings’ investors, Manuel Evangelista, transferred Clover Top Holding’s assets and subsidiaries to several other entities.” Hmmmmm. That competing marijuana operation would be North Star Holdings.
https://brokercheck.finra.org/individual/summary/2309807 “FINRA has barred this individual (Kaweske) from acting as a broker or otherwise associating with a broker-dealer firm.”
https://www.offshorealert.com/tag/john-kaweske/ “Fresh from the collapse of his fraudulently operated Cayman Islands based stock brokerage SEGOES Securities with a net insolvency of approximately $10 million, John Kaweske, Jr. has re emerged in recent months through the creation of his own fantasy world” …. “The liquidators of offshore stockbroker SEGOES Services Ltd. have obtained a court judgment for US$3.9 million against the firm's principal director, John Kaweske, Jr.”
Sounds like Mr Kaweske (North Star Holdings, et al) and George S. Ackerson (Safer Medical Montana, et al) both graduated from the same Bogus Business School, and majored in bad business ethics.
Recent PBIO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2024 08:05:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2024 08:05:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2024 08:05:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2024 08:05:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/06/2024 09:17:19 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/19/2024 09:20:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 04:32:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/07/2024 09:28:07 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/27/2024 06:42:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 10:30:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:24:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:24:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:24:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:24:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:24:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:24:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:44:21 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 08:18:45 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM